Vaccines Market Growth (8.3% CAGR) to 2021 led by N. America
PUNE, India, August 12, 2016 /PRNewswire/ --
The vaccines market is expected to reach $48.03 billion by 2021 from USD 32.24 billion in 2016 at a CAGR of 8.3% driven by increasing focus on immunization programs and rising government and nongovernment funding for vaccine development while North America is expected to dominate the market globally.
Complete report on vaccines market spread across 158 pages, profiling 10 companies and supported with 89 tables and 55 figures is now available at http://www.rnrmarketresearch.com/vaccine-market-by-technology-types-trend-analysis-by-various-classes-live-attenuated-subunit-toxoid-conjugate-dna-recombinant-vector-synthetic-dentritic-vaccines-and-by-indications-i-market-report.html.
The global vaccines market is segmented based on technology, type, disease indication, end-users, and regions. The conjugate vaccines segment is expected to register the highest growth rate in the vaccines market, by technology, during the forecast period. The high growth in this segment is attributed to the increasing company investments in development of new vaccines.
Based on end-users, the vaccines market is segmented into pediatrics and adults. The pediatrics segment is expected to account for the largest share of the market in 2016. Increasing prevalence of diseases in children and the rising number of awareness programs to promote vaccination will drive the growth of this market.
Geographically, the vaccines market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising government funding for vaccine research in the North American countries.
The major factors contributing to the growth of the vaccines market include high prevalence of diseases; rising government and nongovernment funding for vaccine development, and increasing focus on immunization programs. Furthermore, increasing R&D spending and new vaccine development activities by companies is another major factor driving the growth of this market.
The major players in this market include Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Merck & Co. (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur (France), and Serum Institute of India Pvt. Ltd. (India). Order a copy of Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021 research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=110437.
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach and levels of output in order to remain successful in the market.
On a related note, another research on Veterinary / Animal Vaccines Market Global Forecast to 2020 says, increasing investments by various government agencies, animal associations, & leading players to drive the growth of the veterinary vaccines market. From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and sub segments, competitive landscape, and company profiles. Companies like Zoetis Inc., Merck Animal Health, Merial Inc., Boehringer Ingelheim, Bayer Animal Health, Elanco Animal Health, Ceva Animal Health, Heska Corporation and Virbac Inc. have been profiled in this 250 pages research report available at http://www.rnrmarketresearch.com/veterinary-animal-vaccines-market-by-product-livestock-companion-poultry-equine-porcine-diseases-rabies-distemper-foot-mouth-gumboro-swine-avian-influenza-strangles-technology-li-market-report.html.
Explore more reports on Life Sciences market at http://www.rnrmarketresearch.com/reports/life-sciences.
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
[email protected]
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
Twitter: https://twitter.com/RnRMR
Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345
RSS / Feeds: http://www.rnrmarketresearch.com/feed
SOURCE RnR Market Research
Share this article